-
As you review the list of contraceptive options available at your family planning facility with your next female patient, which one most likely will receive the nod from her?
-
-
On Aug. 26, the U.S. Food and Drug Administration (FDA) announced that it would indefinitely postpone its decision to allow nonprescription status for the emergency contraceptive pill Plan B popularly known as the morning-after pill.
-
As you check the chart of a new patient, you note that she has previously experienced nausea on birth control pills, but cant remember the brand name of her prescribed oral contraceptive (OC). She would like to re-establish pill use. Which OC will you suggest?
-
The young woman sitting in front of you is in good health and says she would like to use a birth control pill. Which pill do you prescribe?
-
Lacey and colleagues from the National Cancer Institute report the risks of endometrial cancer in users of combined estrogen-progestin regimens.
-
The Danish Nurse Cohort was established in 1993. A total 10,874 women were available for follow-up after excluding hysterectomized women and cases of breast cancer identified at baseline.
-
The Safety of Estrogens in Lupus Erythematosus, National Assessment (SELENA) was composed of 2 randomized, placebo-controlled, multicenter trialsone with estrogen-progestin therapy in postmenopausal women and one comparing oral contraceptives and placebo.
-
The prevalence of depression among low-income, ethnic minority women with breast or gynecologic cancer is largely unknown, but limited formal screening programs and restricted access to effective therapies would suggest the number to be high.
-
Shoulder dystocia is one of the most stressful situations facing a patient, her fetus, and her provider. In the worst case, it can result in a rare infant death or disability. A problem that occasionally surfaces is brachial palsy, and this, in turn, not infrequently finds its way into the courts.